Jakarta - Delayed Quote IDR

PT Kalbe Farma Tbk. (KLBF.JK)

1,560.00
+45.00
+(2.97%)
At close: 4:13:04 PM GMT+7

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in IDR.
NameTitlePayExercisedYear Born
Ms. Bernadette Ruth Irawati Setiady MSc. President Director -- -- 1962
Mr. Sie Djohan Director of Corporate Business Development, Management System & Regulatory Affairs and Director -- -- 1967
Mr. Rustam Tan Head of Internal Audit Unit -- -- 1970
Maria Teresa Fabiola Corporate Secretary -- -- 1972

PT Kalbe Farma Tbk.

Gedung KALBE
Jl. Let. Jend. Suprapto Kav. 4 Cempaka Putih
Jakarta, 10510
Indonesia
62 21 4287 3888 https://www.kalbe.co.id
Sector: 
Healthcare
Full Time Employees: 
12,841

Description

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic divisions. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. The company was incorporated in 1966 and is based in Jakarta, Indonesia.

Corporate Governance

PT Kalbe Farma Tbk.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

June 4, 2025 at 12:00 AM UTC

Ex-Dividend Date

July 29, 2025 at 10:59 AM UTC - August 4, 2025 at 12:00 PM UTC

PT Kalbe Farma Tbk. Earnings Date

Recent Events

Related Tickers